Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × liposomal doxorubicin × 90 days × Clear all

Sponsor

Conditions

Ovarian Neoplasms 14 Fallopian Tube Neoplasms 10 Breast Neoplasms 8 Sarcoma 5 Neoplasms 4 Neoplasm Metastasis 4 Triple Negative Breast Neoplasms 3 Sarcoma, Kaposi 2 Sarcoma, Ewing 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Multi-centric Castleman's Disease 2 Leiomyosarcoma 2 Hodgkin Disease 2 Acquired Immunodeficiency Syndrome 2 Vaccinia 1 Sarcoma, Synovial 1 Rhabdomyosarcoma 1 Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma 1 Recurrence 1 Peritoneal Neoplasms 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Macular dystrophy, corneal type 1 1 Lymphoproliferative Disorders 1 Lymphoma, Non-Hodgkin 1 Lymphadenopathy 1 Lung Neoplasms 1 Low Grade Serous Ovarian Cancer 1 Liposarcoma 1 Leukemia-Lymphoma, Adult T-Cell 1

Interventions

pembrolizumab 27 enfortumab vedotin 16 Nivolumab 14 Gemcitabine 12 avelumab 10 Magnetic Resonance Spectroscopy 10 Cisplatin 10 Carboplatin 10 Specimen Handling 9 sacituzumab govitecan 6 atezolizumab 6 durvalumab 5 Ipilimumab 5 Docetaxel 5 Paclitaxel 4 cabozantinib 3 Taxes 3 tislelizumab 2 relatlimab 2 lenvatinib 2 erdafitinib 2 Radiosurgery 2 Platinum 2 Oxaliplatin 2 Immunoglobulin G 2 Fluorodeoxyglucose F18 2 Cyclophosphamide 2 Cryosurgery 2 CTLA-4 Antigen 2 Biopsy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡